Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	312.42	561.57	944.07	1,316	1,550	380.8
Cash & Short-Term Investments	516.92	561.57	944.07	1,316	1,550	380.8
Cash Growth	-38.49%	-40.52%	-28.25%	-15.11%	307.04%	-23.11%
Accounts Receivable	27.17	22.44	17.9	82.47	136.14	21.91
Other Receivables	-	-	-	1.56	-	-
Receivables	27.17	22.44	30.19	84.03	147.7	24.17
Inventory	-	-	-	4.36	3.51	9.27
Prepaid Expenses	12.5	12.89	22.7	35.11	18.94	10.85
Restricted Cash	7.94	5.84	4.79	8.22	-	-
Other Current Assets	-	-	-	2.57	2.9	1.44
Total Current Assets	564.53	602.74	1,002	1,450	1,723	426.54
Property, Plant & Equipment	581.22	598.16	394.99	718.79	145.77	121.44
Long-Term Investments	32.17	48.7	78.57	113.73	115.23	103.12
Goodwill	-	-	49.24	60.21	21.31	1.86
Other Intangible Assets	68.76	72.51	82.74	111.04	21.64	3.29
Other Long-Term Assets	37.88	41.17	44.45	47.81	43.99	5.6
Total Assets	1,293	1,377	1,665	2,539	2,071	675.15
Accounts Payable	11.27	14.17	9.32	10.45	8.19	13.89
Accrued Expenses	65.31	19.19	49.87	52.3	85.14	17.73
Current Portion of Leases	-	28.97	17.47	29.33	0.75	0.49
Current Unearned Revenue	33.65	30.6	48.5	47.82	33.24	28.82
Other Current Liabilities	5.44	14.34	38.7	33.06	7.45	12.29
Total Current Liabilities	115.67	107.27	163.86	172.96	134.76	73.22
Long-Term Leases	434.56	438.79	221.84	413.26	22.28	16.52
Long-Term Unearned Revenue	80.38	98.78	158.06	174.77	155.99	99.65
Other Long-Term Liabilities	15.43	16.55	24.43	42.06	190.58	15.71
Total Liabilities	646.04	661.39	568.19	803.04	503.61	205.1
Common Stock	0.01	0.01	0.01	0.19	0.16	0.13
Additional Paid-In Capital	6,577	6,555	6,386	6,136	3,805	929.13
Retained Earnings	-5,929	-5,838	-5,291	-4,398	-2,298	-467.88
Comprehensive Income & Other	-0.85	-1.81	1.48	-2.63	-1.72	-
Total Common Equity	647.43	716.06	1,097	1,736	1,505	461.38
Minority Interest	-	-	-	-	62.01	8.68
Shareholders' Equity	647.43	716.06	1,097	1,736	1,567	470.05
Total Liabilities & Equity	1,293	1,377	1,665	2,539	2,071	675.15
Total Debt	434.56	467.76	239.31	442.59	23.03	17
Net Cash (Debt)	82.36	93.82	704.76	873.2	1,527	363.8
Net Cash Growth	-86.41%	-86.69%	-19.29%	-42.81%	319.73%	-23.88%
Net Cash Per Share	1.56	1.81	14.50	20.79	44.90	11.42
Filing Date Shares Outstanding	58.53	54.37	50.03	51.81	43.99	7.85
Total Common Shares Outstanding	54.7	54.37	50.03	47.3	40.28	7.85
Working Capital	448.87	495.48	837.89	1,277	1,588	353.32
Book Value Per Share	11.84	13.17	21.93	36.71	37.37	58.77
Tangible Book Value	578.67	643.55	965.17	1,565	1,462	456.23
Tangible Book Value Per Share	10.58	11.84	19.29	33.09	36.30	58.11
Land	6.06	6.06	6.06	6.06	-	-
Buildings	48.29	48.26	47.03	-	-	-
Machinery	165.04	172.33	168.42	206.72	128.75	56.14
Construction In Progress	1.45	1.98	15.83	23.43	10.28	42.58
Leasehold Improvements	140.41	135.96	71.56	125.31	55.03	40.44

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q